Trade-offs between overall survival and side effects in the treatment of metastatic breast cancer: eliciting preferences of patients with primary and metastatic breast cancer using a discrete choice experiment
Adult
Supplementary Information
610
Breast Neoplasms
R Medicine
613
Choice Behavior
decision making
03 medical and health sciences
Health Economics
0302 clinical medicine
SDG 3 - Good Health and Well-being
shared
Humans
Neoplasm Metastasis
Aged
R
SC007342
Patient Preference
Middle Aged
United Kingdom
quality of life
surveys and questionnaires
Medicine
Female
Other
Breast neoplasms
patient preference
DOI:
10.1136/bmjopen-2023-076798
Publication Date:
2024-04-29T07:00:11Z
AUTHORS (7)
ABSTRACT
There has been a recent proliferation in treatment options for patients with metastatic breast cancer. Such treatments often involve trade-offs between overall survival and side effects. Our study aims to estimate the that could be used inform decision-making at individual policy level. We designed discrete choice experiment (DCE) look preferences avoiding severity levels of effects when choosing Treatment attributes were: fatigue, nausea, diarrhoea, other (peripheral neuropathy, hand-foot syndrome mucositis) urgent hospital admission survival. Responses were analysed using an error component logit model. estimated relative importance minimum acceptable improvements The DCE was completed online by UK residents self-reported diagnoses 105 respondents participated, which 72 had cancer 33 primary Overall largest importance, followed effects, nausea fatigue. risk not significant. While most important attribute, willing forgo some absolute probability reductions all Grade 2 (12.02% syndrome, 11.01% mucositis, 10.42% peripheral 6.33% diarrhoea 3.62% nausea). 1 significant, suggesting have general tolerance them. Patients are avoid particular results implications data collected research studies can help person-centred care shared decision-making.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (48)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....